13F

CMPX COMPASS THERAPEUTICS INC

2026Q1 · CUSIP 20454B104 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
200
Δ holders QoQ
+27
Breadth percentile
Top 11%
Whale holders
97
Δ whales
+18
Inst. holding value
$915M
New positions
50
Closed positions
23
Price momentum (1Q)
-71.4%
Put / Call
3/6

Breadth history (34 quarters)

2022Q1: Δ-3 · h=35 2022Q2: Δ+0 · h=35 2022Q3: Δ+4 · h=39 2022Q4: Δ+17 · h=56 2023Q1: Δ+18 · h=74 2023Q2: Δ+0 · h=74 2023Q3: Δ+3 · h=77 2023Q4: Δ+1 · h=78 2024Q1: Δ+2 · h=80 2024Q2: Δ+3 · h=83 2024Q3: Δ-3 · h=80 2024Q4: Δ+13 · h=93 2025Q1: Δ+16 · h=109 2025Q2: Δ-6 · h=103 2025Q3: Δ+22 · h=125 2025Q4: Δ+48 · h=173 2026Q1: Δ+27 · h=200 2022Q1: holders=35 2022Q2: holders=35 2022Q3: holders=39 2022Q4: holders=56 2023Q1: holders=74 2023Q2: holders=74 2023Q3: holders=77 2023Q4: holders=78 2024Q1: holders=80 2024Q2: holders=83 2024Q3: holders=80 2024Q4: holders=93 2025Q1: holders=109 2025Q2: holders=103 2025Q3: holders=125 2025Q4: holders=173 2026Q1: holders=200 -48 -24 +0 +24 +48 31121210 22Q122Q323Q123Q324Q124Q325Q125Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 5 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 11%
2025Q4 Top 11% -71.4%
2025Q3 Top 14% +30.7% -61.3%
2025Q1 Top 15% +28.9% +131.8%
2023Q1 Top 9% -26.5% -54.3%

Options Sentiment

Put holders
3
QoQ: +3
Call holders
6
QoQ: +6

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.40
EPS YoY
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.08 2022-09-30: EPS -0.12 2022-12-31: EPS -0.10 2023-03-31: EPS -0.06 2023-06-30: EPS -0.09 2023-09-30: EPS -0.08 2023-12-31: EPS -0.10 2024-03-31: EPS -0.08 2024-06-30: EPS -0.10 2024-09-30: EPS -0.08 2024-12-31: EPS -0.10 2025-03-31: EPS -0.12 2025-06-30: EPS -0.14 2025-09-30: EPS -0.08 2025-12-31: EPS -0.08 2026-03-31: EPS -0.10 -0.15 -0.08 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)